Predictive Value of BT-RADS Scores for Functional Outcomes and Progression-Free Survival in Glioblastoma

Clicks: 1
ID: 314130
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #10 of 104 articles by views in Neuro-Oncology Advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lay Summary Glioblastoma is an aggressive brain tumor that is often monitored with MRI scans after it is found. The authors of this study wanted to see whether a standardized MRI scoring system called BT-RADS could help predict how patients are functioning and how long the tumor stays under control. To do this, they reviewed MRI reports and health records from 94 adults with glioblastoma and compared BT-RADS scores at about three and nine months with later patient functioning scores and tumor growth. Their results showed that lower BT-RADS scores were linked with better functioning scores and a lower chance of tumor growth during follow-up.
Reference Key
openalex_W7161685132 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Michele Persico, Michael Essien, Tsion Assaye, Laura E Donovan, Jim Zhong, Brent D. Weinberg
Journal Neuro-Oncology Advances
Year 2026
DOI
10.1093/noajnl/vdag094
URL
https://doi.org/10.1093/noajnl/vdag094
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.